3.2. Aurola Treatment Leads to Synergistic ROS-Dependent Cytotoxicity in Mutant p53 NSCLC and PDAC Cell Lines with Low Mutant p53 Protein Levels. Here, TP53 is linked to non-small cell lung carcinoma.